Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FKE01
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $298,240
Award facts
- Contract value 100% obligated
- $298,239.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $298,239.70 by the Defense Logistics Agency (DLA) for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed by October 21, 2025, with the award issued on September 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's pharmaceutical supply support to military healthcare systems globally.
The delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, which provide pharmaceutical products and medical supplies to military treatment facilities and the broader defense health network. GAMUNEX-C is an immunoglobulin therapy used for clinical immunodeficiency conditions, representing the specialized pharmaceutical products that AmerisourceBergen supplies through its federal contracts. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen maintains significant capacity to fulfill federal medical procurement requirements through its established DLA vendor relationship and broad product portfolio spanning specialty medications, generics, vaccines, and related medical supplies.
Quick answers
Who was awarded contract SPE2DB25FKE01?
SPE2DB25FKE01 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE01 worth?
The government has obligated $298,240 on SPE2DB25FKE01.
Is contract SPE2DB25FKE01 an order under another contract?
Yes. SPE2DB25FKE01 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE01 competed?
The extent of competition for SPE2DB25FKE01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award